Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Harrow, Inc. - Common Stock (NQ:HROW)

30.77 +0.23 (+0.75%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 458,784
Open 30.15
Bid (Size) 29.91 (1)
Ask (Size) 30.77 (1)
Prev. Close 30.54
Today's Range 29.78 - 30.86
52wk Range 20.36 - 59.23
Shares Outstanding 36,699,553
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Harrow Appoints Mike Biega as Vice President of Investor Relations and Communications
From Harrow, Inc.
Via Business Wire
William Blair Bullish On Harrow's High-Margin Branded Eye Drug Strategy
Harrow licensed U.S. rights to FDA-approved BYQLOVI for post-surgical eye pain and adds momentum to its branded ophthalmic drug strategy. 
Via Benzinga

Performance

YTD
-15.8%
-15.8%
1 Month
+2.6%
+2.6%
3 Month
+23.2%
+23.2%
6 Month
-8.3%
-8.3%
1 Year
+46.2%
+46.2%

More News

Read More
Assessing Harrow: Insights From 4 Financial Analysts
Via Benzinga
Harrow Acquires U.S. Commercial Rights to BYQLOVI™ (Clobetasol Propionate Ophthalmic Suspension) 0.05% from Formosa Pharmaceuticals
From Harrow, Inc.
Via Business Wire
Earnings Scheduled For May 8, 2025
Via Benzinga
Examining the Future: Harrow's Earnings Outlook
Via Benzinga
Harrow to Present at Two Investor Conferences in May
From Harrow, Inc.
Via Business Wire
Jim Cramer Is 'OK' With Harrow, Recommends Buying This Energy Stock
Via Benzinga
Where Harrow Stands With Analysts
Via Benzinga
Harrow Health Posts Larger Loss In Q1, But Retail Enthusiasm Grows As Dry Eye Disease Drug Drives Revenue
Via Stocktwits
Harrow Announces First-Quarter 2025 Financial Results
From Harrow, Inc.
Via Business Wire
Harrow to Report First Quarter 2025 Financial Results After Market Close on May 8, 2025
From Harrow, Inc.
Via Business Wire
Harrow Expands VEVYE® Access for All Program to ImprimisRx’s Klarity-C Patients
From Harrow, Inc.
Via Business Wire
Where Harrow Stands With Analysts
Via Benzinga
Wondering what's happening in today's after-hours session?
Via Chartmill
Harrow Announces Fourth-Quarter and Year-End 2024 Audited Financial Results
From Harrow, Inc.
Via Business Wire
Harrow To Report Fourth Quarter and Audited Year-End 2024 Financial Results After Market Close on March 27, 2025
From Harrow, Inc.
Via Business Wire
Harrow Announces Transitional Pass-Through Reimbursement Status for TRIESENCE® (Triamcinolone Acetonide Injectable Suspension) 40 mg/mL
From Harrow, Inc.
Via Business Wire
S&P 500 Down 1%; Sarepta Therapeutics Shares Plunge
Via Benzinga
Topics Stocks
Traders are paying attention to the gapping stocks in Tuesday's session.
Via Chartmill
IHS Holding Posts Upbeat Earnings, Joins Tencent Music Entertainment, Elbit Systems And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Discover the top movers in Tuesday's pre-market session.
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
US Futures Show Caution Among Investors Ahead Of FOMC Meeting: Analysts Say Only Certainty Is That 'Things Will Remain Uncertain For The Time Being'
Via Benzinga
Why Harrow Shares Are Trading Higher By 23%; Here Are 20 Stocks Moving Premarket
Via Benzinga

Frequently Asked Questions

Is Harrow, Inc. - Common Stock publicly traded?
Yes, Harrow, Inc. - Common Stock is publicly traded.
What exchange does Harrow, Inc. - Common Stock trade on?
Harrow, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Harrow, Inc. - Common Stock?
The ticker symbol for Harrow, Inc. - Common Stock is HROW on the Nasdaq Stock Market
What is the current price of Harrow, Inc. - Common Stock?
The current price of Harrow, Inc. - Common Stock is 30.77
When was Harrow, Inc. - Common Stock last traded?
The last trade of Harrow, Inc. - Common Stock was at 07/01/25 04:00 PM ET
What is the market capitalization of Harrow, Inc. - Common Stock?
The market capitalization of Harrow, Inc. - Common Stock is 1.13B
How many shares of Harrow, Inc. - Common Stock are outstanding?
Harrow, Inc. - Common Stock has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.